Advantest Corporation

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF (JPY converted to USD at 157.23 JPY/USD): $1.92B normalized FCF base (FY2025 actual, fiscal year ended March 2026, ¥302.2B); 20% annual FCF growth years 1-3; 10% growth years 4-7; 5% growth years 8-10; 10% discount rate; 3% terminal growth; $1.94B net cash; 723.97 million shares outstanding (1:1 ADR ratio for ATEYY).

Reasoning: Advantest is a leading semiconductor automated test equipment maker riding an AI-driven testing demand supercycle (FY2025 sales +44.7%, FCF more than doubling); near-term growth assumptions reflect continued AI/HBM-driven capex before moderating as the test-equipment cycle normalizes and competition from Teradyne and others caps pricing power, with the discount rate reflecting real cyclicality and customer-concentration risk despite the strong balance sheet.